Skip to content

BBNX BBNX Net Income

Net Income at other companies

Insulet logo
InsuletPODD
$91.1M+157%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
-$20.39M+84.4%
Medtronic logo
MedtronicMDT
$1.26B+18.7%
AdaptHealth logo
AdaptHealthAHCO
-$14.87M-145%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$150.05M+27.1%

Other financials

Income statement

See full
Revenue$27.6M+56.6%
Gross profit$16.4M+83.2%
Operating income-$24.3M-30.2%
Net income-$21.9M+23.6%
EPS (diluted)-$0.49+47.3%

Balance sheet

See full
Cash & equivalents$30.2M-28.9%
Total debt$6.9M-0.9%
Total equity$271.2M-13.5%
Total assets$304.4M-9.9%

Cash flow

See full
Operating cash flow-$23.8M-19.3%
CapEx$1.4M+314%
Free cash flow-$25.2M-24.1%

Valuation

See full
Market cap$708.98M-8.6%
Enterprise value$685.68M
P/S6.4×

Profitability

See full
Gross margin57.2%+3.2pp
Operating margin-70.1%-6.4pp
Net margin-60.3%-17.4pp
FCF margin-55.4%-14.3pp

Returns & leverage

See full
Return on equity-22.7%
Debt / equity0.0×
Current ratio10.7×-5.2×

Where this comes from

Reported directly by BBNX in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: BBNX’s 10-Q, filed April 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about BBNX's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BBNX's net income?
BBNX (BBNX) reported net income of -$21.9M in Q1 2026.
How has BBNX's net income changed year-over-year?
BBNX's net income increased by 23.6% year-over-year, from -$28.66M to -$21.9M.
What is the long-term trend for BBNX's net income?
Over 2 years (2023 to 2025), BBNX's net income has grown at a 28.8% compound annual growth rate (CAGR), from -$44.1M to -$73.2M.
What does net income mean?
Net income as the starting point for the indirect method operating cash flow reconciliation.